Three-dose regimen of commercialized IPV

BIOLOGICAL2 trials

Sponsors

Sinovac Biotech Co., Ltd, Jiangsu Province Centers for Disease Control and Prevention

Conditions

Polio and Post-Polio SyndromePoliomyelitis

Phase 1

Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine

CompletedNCT02985320

Sinovac Biotech Co., LtdPoliomyelitis

Start: 2016-10-31End: 2017-06-30Updated: 2017-07-26

Phase 2

Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.

CompletedNCT03902054

Jiangsu Province Centers for Disease Control and PreventionPolio and Post-Polio Syndrome

Start: 2017-12-28End: 2018-12-28Updated: 2019-04-03

Related Papers

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines.

2020-08-316 citations

Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial.

2018-09-2122 citations